Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 415.80
+12.40 (3.07%)
Jun 18, 2026, 4:08 PM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 96.96 billion as of June 18, 2026. Its market cap has increased by 45.86% in one year.
Market Cap
96.96B
Enterprise Value
92.08B
Revenue
2.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
415.80
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 96.96B, an increase of 618.78%. That is a compound annual growth rate of 95.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 96.96B | 6.02% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 235.39B |
| Innovent Biologics | 132.37B |
| WuXi Biologics | 127.40B |
| Sino Biopharmaceutical | 81.66B |
| Akeso | 80.65B |
| RemeGen | 61.20B |
| Biocytogen Pharmaceuticals (Beijing) | 41.22B |
| 3SBio | 40.59B |